Alerts will be sent to your verified email
Verify Email
SUDARSHAN
|
Sudarshan Pharma Ind
|
Sakar Healthcare
|
Kilitch Drugs(India)
|
|
|---|---|---|---|
|
Operational Metrics
|
|||
|
Financials
|
|||
|
5 yr Average ROE
|
11.68 % | 9.28 % | 4.81 % |
|
5yr average Equity Multiplier
|
3.46 | 1.75 | 1.42 |
|
5yr Average Asset Turnover Ratio
|
2.04 | 0.5 | 0.51 |
|
5yr Avg Net Profit Margin
|
1.71 % | 10.38 % | 6.07 % |
|
Price to Book
|
0.0 | 2.28 | 3.21 |
|
P/E
|
39.97 | 41.32 | 31.13 |
|
5yr Avg Cash Conversion Cycle
|
79.33 Days | -14.29 Days | -7.56 Days |
|
Inventory Days
|
48.15 Days | 46.75 Days | 17.9 Days |
|
Days Receivable
|
80.34 Days | 51.16 Days | 138.92 Days |
|
Days Payable
|
72.36 Days | 103.34 Days | 193.35 Days |
|
5yr Average Interest Coverage Ratio
|
2.67 | 5.43 | 5.07 |
|
5yr Avg ROCE
|
21.8 % | 10.08 % | 8.16 % |
|
5yr Avg Operating Profit Margin
|
3.72 % | 24.06 % | 9.07 % |
|
5 yr average Debt to Equity
|
0.91 | 0.47 | 0.14 |
|
5yr CAGR Net Profit
|
33.82 % | 3.94 % | 77.02 % |
|
5yr Average Return on Assets
|
3.4 % | 5.37 % | 3.38 % |
|
Shareholdings
|
|||
|
Promoter Holding
|
57.39 % | 53.58 % | 69.23 % |
|
Share Pledged by Promoters
|
0.0 | 0.0 | 0.0 |
|
Change in Promoter Holding (3 Yrs)
|
-31.89 % | -13.96 % | 0.98 % |
|
Change in Mutual Fund Holding (3 Yrs)
|
0.0 | 0.0 | 0.0 |
|
Sudarshan Pharma Ind
|
Sakar Healthcare
|
Kilitch Drugs(India)
|
|
|---|---|---|---|
|
Product Wise Break-Up
|
Product Wise Break-Up
|
Product Wise Break-Up
|
Product Wise Break-Up
|
|
Location Wise Break-Up
|
Location Wise Break-Up
|
Location Wise Break-Up
|
Location Wise Break-Up
|